Association Between Insulin-Like Growth Factor-1 and Cardiovascular Disease Risk: Evidence from a Meta-Analysis

Zhaohai Jing,Xu Hou,Yali Wang,Yang Gao,Bin Wang,Xin Tian,Shihua Zhao,Yangang Wang

DOI: https://doi.org/10.1016/j.ijcard.2015.06.114

IF: 4.039

2015-01-01

International Journal of Cardiology

Abstract:In recent years, insulin-like growth factor-1 (IGF-1) has been implicated in aging and development of age related diseases, like cardiovascular disease (CVD) and cancer. High serum IGF-I levels have been reported to increase many cancers risk, such as breast cancer [ [1] Green J. Cairns B.J. Casabonne D. Wright F.L. Reeves G. Beral V. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol. 2011; 12: 785-794 Abstract Full Text Full Text PDF PubMed Scopus (263) Google Scholar ], prostate cancer [ [2] Zuccolo L. Harris R. Gunnell D. Oliver S. Lane J.A. Davis M. et al. Height and prostate cancer risk: a large nested case–control study (ProtecT) and meta-analysis. Cancer Epidemiol. Biomark. Prev. 2008; 17: 2325-2336 Crossref PubMed Scopus (77) Google Scholar ], thyroid cancer [ [3] Jing Z. Hou X. Liu Y. Yan S. Wang R. Zhao S. et al. Association between height and thyroid cancer risk: a meta-analysis of prospective cohort studies. Int. J. Cancer. 2015; https://doi.org/10.1002/ijc.29487 Crossref Scopus (12) Google Scholar ] and so on. IGF-1 is a 70-amino acid basic peptide hormone that is expressed in most tissues. IGF-1 is homologous to pro-insulin, primarily synthesized in liver and kidney, which reconciles and regulates the cell proliferation, apoptosis, migration, and differentiation [ 4 Foncea R. Andersson M. Ketterman A. Blakesley V. Sapag-Hagar M. Sugden P.H. et al. Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J. Biol. Chem. 1997; 272: 19115-19124 Crossref PubMed Scopus (174) Google Scholar , 5 Fazio S. Palmieri E.A. Biondi B. Cittadini A. Sacca L. The role of the GH-IGF-I axis in the regulation of myocardial growth: from experimental models to human evidence. Eur. J. Endocrinol. 2000; 142: 211-216 Crossref PubMed Scopus (47) Google Scholar , 6 Meyers D.E. Cuneo R.C. Controversies regarding the effects of growth hormone on the heart. Mayo Clin. Proc. 2003; 78: 1521-1526 Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar ]. Also, IGF-1 can regulate the vascular smooth muscle cell. Recent studies showed that the apoptosis of vascular smooth muscle cell could be a marker of unstable atherosclerotic plaques, leading to acute vascular events [ [7] Delafontaine P. Song Y.H. Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler. Thromb. Vasc. Biol. 2004; 24: 435-444 Crossref PubMed Scopus (438) Google Scholar ]. Several epidemiological studies had assessed the relationship between IGF-1 levels and risk of CVD, but the results were not consistent [ 8 Janssen J.A. Stolk R.P. Pols H.A. Grobbee D.E. de Jong F.H. Lamberts S.W. Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. Clin. Endocrinol. 1998; 48: 471-478 Crossref PubMed Scopus (89) Google Scholar , 9 Juul A. Scheike T. Davidsen M. Gyllenborg J. Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case–control study. Circulation. 2002; 106: 939-944 Crossref PubMed Scopus (538) Google Scholar , 10 Vasan R.S. Sullivan L.M. D'Agostino R.B. Roubenoff R. Harris T. Sawyer D.B. et al. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann. Intern. Med. 2003; 139: 642-648 Crossref PubMed Scopus (237) Google Scholar , 11 Kaplan R.C. McGinn A.P. Pollak M.N. Kuller L.H. Strickler H.D. Rohan T.E. et al. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J. Clin. Endocrinol. Metab. 2007; 92: 1319-1325 Crossref PubMed Scopus (101) Google Scholar , 12 Schneider H.J. Klotsche J. Saller B. Bohler S. Sievers C. Pittrow D. et al. Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients. Eur. J. Endocrinol. 2008; 158: 153-161 Crossref PubMed Scopus (40) Google Scholar , 13 Page J.H. Ma J. Pollak M. Manson J.E. Hankinson S.E. Plasma insulinlike growth factor 1 and binding-protein 3 and risk of myocardial infarction in women: a prospective study. Clin. Chem. 2008; 54: 1682-1688 Crossref PubMed Scopus (19) Google Scholar , 14 Lawlor D.A. Ebrahim S. Smith G.D. Cherry L. Watt P. Sattar N. The association of insulin-like-growth factor 1 (IGF-1) with incident coronary heart disease in women: findings from the prospective British Women's Heart and Health Study. Atherosclerosis. 2008; 201: 198-204 Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar , 15 Andreassen M. Raymond I. Kistorp C. Hildebrandt P. Faber J. Kristensen L.O. IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. Eur. J. Endocrinol. 2009; 160: 25-31 Crossref PubMed Scopus (94) Google Scholar , 16 Friedrich N. Aumann N. Dorr M. Felix S.B. Nauck M. Wallaschofski H. et al. Lack of association between insulin-like growth factor-1 or insulin-like growth factor-binding protein-3 and left ventricular hypertrophy: results of the Study of Health in Pomerania. J. Hypertens. 2010; 28: 856-864 Crossref PubMed Scopus (14) Google Scholar , 17 Ruidavets J.B. Luc G. Machez E. Genoux A.L. Kee F. Arveiler D. et al. Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: the PRIME study. Atherosclerosis. 2011; 218: 464-469 Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar , 18 Ricketts S.L. Rensing K.L. Holly J.M. Chen L. Young E.H. Luben R. et al. Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease. Int. J. Mol. Epidemiol. Genet. 2011; 2: 261-285 PubMed Google Scholar , 19 Carlzon D. Svensson J. Petzold M. Karlsson M.K. Ljunggren O. Tivesten A. et al. Both low and high serum IGF-1 levels associate with increased risk of cardiovascular events in elderly men. J. Clin. Endocrinol. Metab. 2014; 99: E2308-E2316 Crossref PubMed Scopus (30) Google Scholar ]. Based on the current understanding, we performed this systematic review and meta-analysis to get a more precise assessment of the impact of IGF-1 levels on CVD risk.